Financial Express reports that India's Dr. Reddy's Laboratories, based in the southern city of Hyderabad, disclosed plans to expand in the U.S. and emerging markets this year; widen its reach in Europe; invest in new drugs that offer higher margins such as complex generics, biosimilars and proprietary products; and promote...